KR20220099189A - Composition for preventing alopecia and activating growth of hair comprising distilled extract of rare earth complexbiomineral - Google Patents

Composition for preventing alopecia and activating growth of hair comprising distilled extract of rare earth complexbiomineral Download PDF

Info

Publication number
KR20220099189A
KR20220099189A KR1020210000835A KR20210000835A KR20220099189A KR 20220099189 A KR20220099189 A KR 20220099189A KR 1020210000835 A KR1020210000835 A KR 1020210000835A KR 20210000835 A KR20210000835 A KR 20210000835A KR 20220099189 A KR20220099189 A KR 20220099189A
Authority
KR
South Korea
Prior art keywords
weight
composition
hair
extract
hair growth
Prior art date
Application number
KR1020210000835A
Other languages
Korean (ko)
Other versions
KR102489107B1 (en
Inventor
조용국
Original Assignee
엘리펀 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 엘리펀 주식회사 filed Critical 엘리펀 주식회사
Priority to KR1020210000835A priority Critical patent/KR102489107B1/en
Publication of KR20220099189A publication Critical patent/KR20220099189A/en
Application granted granted Critical
Publication of KR102489107B1 publication Critical patent/KR102489107B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13Coniferophyta (gymnosperms)
    • A61K36/14Cupressaceae (Cypress family), e.g. juniper or cypress
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/752Citrus, e.g. lime, orange or lemon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/78Saururaceae (Lizard's-tail family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9755Gymnosperms [Coniferophyta]
    • A61K8/9761Cupressaceae [Cypress family], e.g. juniper or cypress
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions
    • A61K2800/5922At least two compounds being classified in the same subclass of A61K8/18

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

The present invention provides a composition for preventing hair loss and promoting hair growth containing a distilled extract of rare earth element complex bio-mineral matters as an active ingredient, and the composition of the present invention shortens the cycle of transition from telogen phase to anagen phase of the hair growth cycle, thereby having an excellent effect of allowing new hair grow faster.

Description

희토류 복합바이오광물질의 증류추출액을 유효성분으로 함유하는 탈모방지 및 모발성장 촉진제 조성물{COMPOSITION FOR PREVENTING ALOPECIA AND ACTIVATING GROWTH OF HAIR COMPRISING DISTILLED EXTRACT OF RARE EARTH COMPLEXBIOMINERAL}A composition for preventing hair loss and promoting hair growth comprising a distillate extract of rare earth complex bio-mineral as an active ingredient

본 발명은 탈모방지 및 모발 성장 촉진제 조성물에 관한 것으로, 보다 구체적으로는 유효성분으로서 모발의 성장 주기 가운데 휴지기에서 성장기로 이행하는 주기를 단축시켜 새로운 모발이 빨리 자라게 하는 효과가 우수한 희토류 복합바이오광물질의 증류추출액을 유효성분으로 함유하는 탈모방지 및 모발 성장 촉진제 조성물에 관한 것이다.The present invention relates to a hair loss prevention and hair growth promoter composition, and more specifically, as an active ingredient, a rare earth complex bio-mineral excellent in the effect of shortening the transition from the resting to the growing phase among the hair growth cycle, thereby making new hair grow faster. It relates to a hair loss prevention and hair growth promoter composition containing a distillate extract as an active ingredient.

인체의 모발은 약 10 만 내지 15 만 개 정도이며, 각각의 모발은 서로 다른 주기를 가지며 성장기(anagen), 퇴행기(catagen), 휴지기(telogen)를 거쳐 성장, 탈락한다. 이러한 주기는 3-6 년에 걸쳐 반복되는데 그 결과 일일 평균 50 내지 100 개의 모발이 정상적으로 탈락하게 된다. 일반적으로 탈모증이라 함은 이러한 주기 중에서 성장기의 모발 비율이 짧아지고 퇴행기 또는 휴지기의 모발이 많아져 비정상적으로 모발이 탈락하는 숫자가 많아지는 것을 일컫는다.There are about 100,000 to 150,000 hairs in the human body, and each hair has a different cycle and grows and falls out through anagen, catagen, and telogen. This cycle is repeated over 3-6 years, resulting in an average of 50 to 100 hairs falling out normally per day. In general, alopecia refers to an increase in the number of abnormal hair loss due to the shortening of the proportion of hair in the growth phase and more hair in the degenerative phase or telogen phase among these cycles.

탈모의 원인으로는 남성호르몬 과다 분비, 지루성 두피, 스트레스, 비만, 과산화물, 세균 등에 의한 두피 기능 저하등이 논의되어 왔었다. 그러나, 현재까지 탈모에 관한 명확한 원인은 밝혀져 있지 않으며, 최근 들어 식생활의 변화, 사회환경 등에 의한 스트레스의 증가 등으로 탈모로 고민하는 인구가 늘어나고 있는 추세이고 그 연령 또한 낮아지고 있으며, 여성의 탈모 인구도 늘어나고 있는 실정이다.Causes of hair loss include excessive secretion of male hormones, seborrheic scalp, stress, obesity, peroxide, and decreased scalp function due to bacteria, etc. have been discussed. However, the clear cause of hair loss is not known so far, and in recent years, the number of people suffering from hair loss due to changes in diet and increase in stress caused by social environment, etc., is increasing, and the age is also decreasing, and the hair loss population of women is also increasing.

최근의 연구로부터 탈모의 주요한 요인으로 남성호르몬인 안드로겐의 환원형 물질인 디하이드로테스토스테론이 주목받고 있다. 남성호르몬인 테스토스테론은 5α-reductase(5α-환원효소)의 작용에 의해 디하이드로테스토스테론으로 전환되는데, 탈모 환자들의 모낭에는 5α-reductase의 활성도가 높고, 이로 인해 탈모를 일으키는 것으로 알려지고 있다.From recent studies, dihydrotestosterone, a reduced form of androgens, a male hormone, is attracting attention as a major factor in hair loss. Testosterone, a male hormone, is converted to dihydrotestosterone by the action of 5α-reductase (5α-reductase).

이와 같은 탈모의 원인을 치유하기 위하여, 머크사는 5α-reductase의 작용을 저해하여 디하이드로테스토스테론의 생성을 억제하는 약으로서, 피나스테라이드를 개발하여 시판하고 있으나, 다양한 부작용이 보고되고 있다. In order to cure such a cause of hair loss, Merck Corporation has developed and marketed finasteride as a drug for inhibiting the production of dihydrotestosterone by inhibiting the action of 5α-reductase, but various side effects have been reported.

본 발명은 상기한 바와 같이 종래기술이 가지는 문제를 해결하기 위해 제안된 것으로, 그 목적은 모발의 성장 주기 가운데 휴지기에서 성장기로 이행하는 주기를 단축시켜 새로운 모발이 빨리 자라게 하는 효과가 우수한 희토류 복합바이오광물질을 유효성분으로 함유하는 탈모방지 및 모발 성장 촉진제 조성물을 제공하는 것이다.The present invention has been proposed to solve the problems of the prior art as described above, and the purpose of the present invention is to shorten the transition period from the resting period to the anagen phase among the hair growth cycle, thereby providing an excellent effect of rapidly growing new hair. It is to provide a composition for preventing hair loss and promoting hair growth containing a mineral as an active ingredient.

상기한 바와 같은 본 발명의 기술적 과제는 다음과 같은 수단에 의해 달성되어진다.The technical problem of the present invention as described above is achieved by the following means.

(1) 희토류 복합바이오광물질의 증류추출액을 활성성분으로 함유하는 탈모방지 및 모발성장 촉진제 조성물.(1) A composition for preventing hair loss and promoting hair growth containing a distillate extract of rare earth complex bio-mineral as an active ingredient.

(2) 상기 (1)에 있어서,(2) in (1) above,

상기 희토류 복합바이오광물질은 F 0.1~0.2중량%, Na2O 0.1~0.2중량%, MgO 0.08~0.09중량%, Al2O3 34.0~35.0중량%, SiO2 58.0~59.0중량%, P2O5 0.04~0.05중량%, SO3 0.01~0.02중량%, Cl 0.003~0.004중량%, K2O 2.8~2.9중량%, CaO 0.008~0.009중량%, TiO2 1.5~1.6중량%, Cr2O3 0.01~0.02중량%, MnO 0.01~0.02중량%, Fe2O3 1.0~2.0중량%, NiO 0.005~0.006중량%, CuO 0.002~0.003중량%, Ga2O5 0.006~0.007중량%, SrO 0.02~0.03중량%, Y2O3 0.005~0.006중량%, ZrO2 0.02~0.03중량%, BaO 0.05~0.06중량%, ReO2 0.006~0.007중량%, PbO 0.004~0.005중량%, TbO2 0.002~0.003중량%, Pa 0.02~0.03중량%를 포함하는 것을 특징으로 하는 탈모방지 및 모발성장 촉진제 조성물.The rare earth composite bio-mineral material is F 0.1 to 0.2 wt%, Na 2 O 0.1 to 0.2 wt%, MgO 0.08 to 0.09 wt%, Al 2 O 3 34.0 to 35.0 wt%, SiO 2 58.0 to 59.0 wt%, P 2 O 5 0.04~0.05 wt%, SO 3 0.01~0.02 wt%, Cl 0.003~0.004 wt%, K 2 O 2.8~2.9 wt%, CaO 0.008~0.009 wt%, TiO 2 1.5~1.6 wt%, Cr 2 O 3 0.01 to 0.02 wt%, MnO 0.01 to 0.02 wt%, Fe 2 O 3 1.0 to 2.0 wt%, NiO 0.005 to 0.006 wt%, CuO 0.002 to 0.003 wt%, Ga 2 O 5 0.006 to 0.007 wt%, SrO 0.02 to 0.03 wt%, Y 2 O 3 0.005 to 0.006 wt%, ZrO 2 0.02 to 0.03 wt%, BaO 0.05 to 0.06 wt%, ReO 2 0.006 to 0.007 wt%, PbO 0.004 to 0.005 wt%, TbO 2 0.002 to 0.003 wt% %, Pa 0.02 to 0.03% by weight of hair loss prevention and hair growth promoter composition, characterized in that it comprises.

(3) 상기 (1)에 있어서, 상기 증류추출액은,(3) In the above (1), the distillate extract,

상기 희토류 복합바이오광물질을 물과 함께 증류기에 넣고 온도 110~130℃로 1~10시간 동안 가열한 후, 증류시켜 얻어진 것을 특징으로 하는 탈모방지 및 모발성장 촉진제 조성물.The composition for preventing hair loss and promoting hair growth, characterized in that it is obtained by distilling the rare earth complex biomineral material together with water in a distiller, heating it at a temperature of 110 to 130° C. for 1 to 10 hours, and then distilling.

(4) 상기 (1)에 있어서,(4) in (1) above,

상기 증류추출액과 함께 어성초, 측백잎, 모려분, 유근피, 백선피, 및 지실의 증류추출액을 더 포함하는 것을 특징으로 하는 탈모방지 및 모발성장 촉진제 조성물.Hair loss prevention and hair growth promoter composition, characterized in that it further comprises a distillate extract of eoseongcho, chrysanthemum leaf, morya powder, eugeunpi, baekseonpi, and lichen together with the distillate extract.

(5) 상기 (4)에 있어서,(5) in (4) above,

상기 증류추출액 10~70중량%, 어성초 1~20 중량%, 녹차잎 1~20중량%, 박화수잎 1~20중량%, 측백잎 1~20중량%, 및 소엽 1~20중량%를 증류기에 투입하여 증류시켜 얻어진 피부개선추출액을 포함하는 것을 특징으로 하는 탈모방지 및 모발성장 촉진제 조성물.10 to 70% by weight of the distillation extract, 1 to 20% by weight of Eoseongcho, 1 to 20% by weight of green tea leaves, 1 to 20% by weight of squash leaves, 1 to 20% by weight of arborvitae leaf, and 1 to 20% by weight of leaflets in a distillation A composition for preventing hair loss and promoting hair growth, characterized in that it contains a skin improvement extract obtained by distillation.

본 발명에 의하면, 모발의 성장 주기 가운데 휴지기에서 성장기로 이행하는 주기를 단축시켜 새로운 모발이 빨리 자라게 하는 효과가 우수한 것으로 나타났다.According to the present invention, it has been shown that the effect of shortening the transition period from the resting period to the growth period among the hair growth period is excellent, so that new hair grows faster.

본 발명에 따른 탈모방지 및 모발성장 촉진제 조성물은 희토류 복합바이오광물질의 증류추출액을 활성성분으로 포함한다.The composition for preventing hair loss and promoting hair growth according to the present invention includes a distillate extract of rare earth complex bio-mineral as an active ingredient.

본 발명의 상기 희토류 복합바이오광물질은 바람직하게는 F 0.1~0.2중량%, Na2O 0.1~0.2중량%, MgO 0.08~0.09중량%, Al2O3 34.0~35.0중량%, SiO2 58.0~59.0중량%, P2O5 0.04~0.05중량%, SO3 0.01~0.02중량%, Cl 0.003~0.004중량%, K2O 2.8~2.9중량%, CaO 0.008~0.009중량%, TiO2 1.5~1.6중량%, Cr2O3 0.01~0.02중량%, MnO 0.01~0.02중량%, Fe2O3 1.0~2.0중량%, NiO 0.005~0.006중량%, CuO 0.002~0.003중량%, Ga2O5 0.006~0.007중량%, SrO 0.02~0.03중량%, Y2O3 0.005~0.006중량%, ZrO2 0.02~0.03중량%, BaO 0.05~0.06중량%, ReO2 0.006~0.007중량%, PbO 0.004~0.005중량%, TbO2 0.002~0.003중량%, Pa 0.02~0.03중량%를 포함한다.The rare earth composite biomineral of the present invention is preferably F 0.1 to 0.2 wt%, Na 2 O 0.1 to 0.2 wt%, MgO 0.08 to 0.09 wt%, Al 2 O 3 34.0 to 35.0 wt%, SiO 2 58.0 to 59.0 wt%, P 2 O 5 0.04 to 0.05 wt%, SO 3 0.01 to 0.02 wt%, Cl 0.003 to 0.004 wt%, K 2 O 2.8 to 2.9 wt%, CaO 0.008 to 0.009 wt%, TiO 2 1.5 to 1.6 wt% %, Cr 2 O 3 0.01~0.02 wt%, MnO 0.01~0.02 wt%, Fe 2 O 3 1.0~2.0 wt%, NiO 0.005~0.006 wt%, CuO 0.002~0.003 wt%, Ga 2 O 5 0.006~0.007 wt%, SrO 0.02~0.03 wt%, Y 2 O 3 0.005~0.006 wt%, ZrO 2 0.02~0.03 wt%, BaO 0.05~0.06 wt%, ReO 2 0.006~0.007 wt%, PbO 0.004~0.005 wt%, TbO 2 0.002 to 0.003% by weight, including 0.02 to 0.03% by weight of Pa.

본 발명의 상기 희토류 복합바이오광물질은 보다 바람직하게는 태백 예낭광산에서 채취한 하기 표 1 성분조성 분포를 갖는 것으로 한다.The rare earth composite bio-mineral material of the present invention more preferably has the composition distribution in Table 1 below taken from the Yenang Mine in Taebaek.

성분ingredient 중량%weight% FF 0.13580.1358 Na2ONa 2 O 0.11940.1194 MgOMgO 0.08200.0820 Al2O3 Al 2 O 3 34.773934.7739 SiO2 SiO 2 58.557658.5576 P2O5 P 2 O 5 0.04270.0427 SO3 SO 3 0.01050.0105 ClCl 0.00340.0034 K2OK 2 O 2.86952.8695 CaOCaO 0.00800.0080 TiO2 TiO 2 1.50241.5024 Cr2O3 Cr 2 O 3 0.01530.0153 MnOMnO 0.01460.0146 Fe2O3 Fe 2 O 3 1.70341.7034 NiONiO 0.00550.0055 CuOCuO 0.00250.0025 Ga2O5 Ga 2 O 5 0.00650.0065 SrOSrO 0.02550.0255 Y2O3 Y 2 O 3 0.00530.0053 ZrO2 ZrO 2 0.02650.0265 BaOBaO 0.05660.0566 ReO2 ReO 2 0.00650.0065 PbOPbO 0.00400.0040 TbO2 TbO 2 0.00230.0023 PaPa 0.02030.0203 total 100100

상기 본 발명에 따른 희토류 복합바이오광물질의 증류추출액은 상기 표 1의 성분으로 이루어진 원광을 분쇄한 후, 물을 첨가하여 증류냉각하여 얻어지는 것이다. 보다 구체적으로는 상기 희토류 복합바이오광물질을 물과 함께 증류기에 넣고 온도 110~130℃로 1~10시간 동안 가열한 후, 증류시켜 얻어진다.The distillate extract of the rare-earth complex bio-mineral material according to the present invention is obtained by pulverizing the ore composed of the components of Table 1, and then distilling and cooling the ore by adding water. More specifically, it is obtained by putting the rare earth complex biomineral together with water in a distiller and heating it at a temperature of 110 to 130° C. for 1 to 10 hours, followed by distillation.

상기 본 발명에 따른 희토류 복합바이오광물질의 증류추출액(이하, 「EF 21」로 칭한다)은 모발의 성장 주기 가운데 휴지기에서 성장기로 이행하는 주기를 단축시켜 새로운 모발이 빨리 자라게 하는 효과가 탁월하다.The distillation extract of the rare earth complex bio-mineral according to the present invention (hereinafter referred to as "EF 21") is excellent in the effect of shortening the transition period from the resting phase to the growth phase among the hair growth cycle, thereby making new hair grow faster.

본 발명에 따른 조성물은 상기 EF 21 40~70중량%와 함께, 바람직하게는 탈모방지 및 모발성장을 증진하기 위해 바람직하게는 어성초, 녹차잎, 박화수잎, 측백잎, 및 소엽에서 선택되는 적어도 1종의 증진제 혹은 이의 추출물을 각각 10~30 중량%, 보다 바람직하게는 어성초 1~20 중량%, 녹차잎 1~20중량%, 박화수잎 1~20중량%, 측백잎 1~20중량%, 및 소엽 1~20중량%를 증류기에 투입하여 온도 110~130℃로 1~10시간 동안 가열하여, 증류시켜 얻어진 증진제를 포함하는 탈모방지 및 모발성장용 추출액을 0.1~99.9 중량% 포함한다.The composition according to the present invention, together with 40 to 70% by weight of the EF 21, preferably at least 1 selected from eosincho, green tea leaves, chrysanthemum leaves, chrysanthemum leaves, and leaflets in order to prevent hair loss and promote hair growth. Each of the species enhancer or its extract is 10 to 30% by weight, more preferably 1 to 20% by weight of Eosongcho, 1 to 20% by weight of green tea leaves, 1 to 20% by weight of Bakhwasoo leaves, 1 to 20% by weight of chrysanthemum leaves, and It contains 0.1 to 99.9 wt% of an extract for preventing hair loss and hair growth including an enhancer obtained by distilling 1 to 20% by weight of the leaflets into a distiller and heating at a temperature of 110 to 130° C. for 1 to 10 hours.

상기 본 발명에 따른 조성물은 통상적으로 이용되는 성분들을 포함할 수 있으며, 예컨대 항산화제, 안정화제, 용해화제, 비타민, 안료 및 향료와 같은 통상적인 보조제, 그리고 담체를 포함한다.The composition according to the present invention may include commonly used components, for example, conventional adjuvants such as antioxidants, stabilizers, solubilizers, vitamins, pigments and fragrances, and carriers.

본 발명의 조성물은 당업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 예를 들어, 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제-함유 클린싱, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션 및 스프레이 등으로 제형화될 수 있으나, 이에 한정되는 것은 아니다. 보다 상세하게는, 유연 화장수, 수렴 화장수, 영양 화장수, 영양 크림, 마사지 크림, 에센스, 아이 크림, 클렌징 크림, 클렌징 포옴, 클렌징워터, 팩, 스프레이 또는 파우더의 제형으로 제조될 수 있다.The composition of the present invention may be prepared in any formulation conventionally prepared in the art, for example, solutions, suspensions, emulsions, pastes, gels, creams, lotions, powders, soaps, surfactant-containing cleansing, It may be formulated as oil, powder foundation, emulsion foundation, wax foundation and spray, but is not limited thereto. More specifically, it may be prepared in the form of a flexible lotion, astringent lotion, nourishing lotion, nourishing cream, massage cream, essence, eye cream, cleansing cream, cleansing foam, cleansing water, pack, spray or powder.

본 발명의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물성유, 식물성유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다.When the formulation of the present invention is a paste, cream or gel, animal oil, vegetable oil, wax, paraffin, starch, tracanth, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide may be used as a carrier component. can

본 발명의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판/부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.When the formulation of the present invention is a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as a carrier component, and in particular, in the case of a spray, additional chlorofluorohydrocarbon, propane /may contain propellants such as butane or dimethyl ether.

본 발명의 제형이 용액 또는 유탁액인 경우에는 담체 성분으로서 용매, 용해화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌 글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 있다.When the formulation of the present invention is a solution or emulsion, a solvent, solubilizer or emulsifier is used as a carrier component, such as water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1 ,3-butylglycol oil, glycerol fatty esters, fatty acid esters of polyethylene glycol or sorbitan.

본 발명의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상의 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있다.When the formulation of the present invention is a suspension, as a carrier component, a liquid diluent such as water, ethanol or propylene glycol, a suspending agent such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, microcrystals Adult cellulose, aluminum metahydroxide, bentonite, agar or tracanth may be used.

본 발명의 제형이 계면-활성제 함유 클린징인 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르 설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성 유, 라놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있다.When the formulation of the present invention is a surfactant-containing cleansing agent, aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyl taurate, sarcosinate, fatty acid amide as carrier components Ether sulfate, alkylamidobetaine, fatty alcohol, fatty acid glyceride, fatty acid diethanolamide, vegetable oil, lanolin derivative or ethoxylated glycerol fatty acid ester and the like can be used.

본 발명에 따른 조성물은 상기 각 활성성분 이외에 조성물의 제형에 있어서 통상적으로 사용될 수 있는 담체를 포함할 수 있다. 이러한 담체의 예로서는 알코올, 오일, 계면활성제, 지방산, 실리콘 오일, 습윤제, 보습제, 점성 변형제, 유제, 방부제, 안정제, 자외선 차단제, 발색제, 향료 등을 들 수 있다. 상기 담체는 본 발명의 조성물 전체 중량에 대하여 약 0.5 중량% 내지 약 99.99 중량%, 바람직하게는 조성물의 중량의 약 80 중량% 내지 약 99.99 중량%로 포함될 수 있다.The composition according to the present invention may include a carrier that can be conventionally used in the formulation of the composition in addition to each of the above active ingredients. Examples of such carriers include alcohols, oils, surfactants, fatty acids, silicone oils, humectants, humectants, viscosity modifiers, emulsifiers, preservatives, stabilizers, sunscreens, coloring agents, fragrances, and the like. The carrier may be included in an amount of about 0.5% to about 99.99% by weight based on the total weight of the composition of the present invention, preferably about 80% by weight to about 99.99% by weight of the weight of the composition.

또한 본 발명에 따른 탈모방지 및 모발성장 효과를 가지는 조성물은 통상적인 사용방법에 따라 사용될 수 있으며, 사용자의 상태 또는 취향에 따라 그 사용횟수를 달리할 수 있다.In addition, the composition having the effect of preventing hair loss and hair growth according to the present invention can be used according to a conventional method of use, and the number of times of use can be varied according to the user's condition or taste.

이하 본 발명의 내용을 실시예에 의해 보다 구체적으로 설명하기로 한다. 다만 이들 실시예 및 실험예는 본 발명의 이해를 위해 예시되는 것일 뿐 본 발명의 권리범위를 제한하지는 아니함을 유의해야 한다.Hereinafter, the contents of the present invention will be described in more detail by way of examples. However, it should be noted that these Examples and Experimental Examples are merely illustrative for the understanding of the present invention and do not limit the scope of the present invention.

[실시예] 탈모방지 및 모발성장용 추출액의 조제[Example] Preparation of extract for hair loss prevention and hair growth

상기 표 1의 조성을 갖는 희토류 복합바이오광물질의 분말 5kg을 물 20리터와 함께 증류기에 넣고 온도 130℃로 5시간 동안 증류하여 추출액 EF 21을 얻었다. 5 kg of the powder of the rare earth complex bio-mineral having the composition of Table 1 was put in a distiller together with 20 liters of water and distilled at a temperature of 130° C. for 5 hours to obtain an extract EF 21.

그런 다음 상기 EF 21 60 중량%와 함께, 어성초 20 중량%, 녹차잎 10 중량%, 박화수잎 10중량%, 측백잎 5중량%, 및 소엽 5중량%를 증류기에 투입하여 온도 130℃로 6시간 동안 가열하여, 증류시켜 본 발명의 탈모방지 및 모발성장용 추출액을 얻었다.Then, along with the EF 21 60% by weight, 20% by weight of eoseongcho, 10% by weight of green tea leaves, 10% by weight of sagebrush leaves, 5% by weight of arborvitae leaf, and 5% by weight of leaflets were added to the still, and the temperature was 130° C. for 6 hours. It was heated and distilled to obtain the extract for preventing hair loss and hair growth of the present invention.

[실험예] 모발 성장기 유도 촉진 작용 평가 실험[Experimental Example] Evaluation of hair growth phase induction promoting action

모발 성장기 유도 촉진 효과 실험은 모발 성장기 유도 작용 평가에 널리 이용되고 있는 생후 7주가 된 마우스(C57BL/6, female)를 사용하였다. 먼저 마우스의 등 부위의 털을 전기면도기를 이용하여 제거하고 각 마우스의 무게를 재서 몸무게가 골고루 분산이 되도록 10마리씩 나누었다. 제모 부위에 부형약, 대조약, 본 발명 실시예의 추출액을 도포하였으며, 이때 부형약으로는 95% 에탄올을, 대조약은 2% 미녹시딜을, 시험약으로는 실시예의 추출액을 각각 95% 에탄올로 희석하여 최종농도 0.5%로 제조하여 사용하였다. 마우스 개체당 등 부위에 1일 1회, 붓으로 충분히 도포하였다. For the hair growth phase induction promoting effect experiment, a 7-week-old mouse (C57BL/6, female), which is widely used to evaluate the hair growth phase induction effect, was used. First, the hairs on the back of the mice were removed using an electric razor, and each mouse was weighed and divided into 10 mice so that the weight was evenly distributed. The excipient, the control drug, and the extract of Examples of the present invention were applied to the hair removal site, and at this time, 95% ethanol as the excipient, 2% minoxidil as the control drug, and 95% ethanol as the test drug, respectively, the extract of Example was diluted Thus, a final concentration of 0.5% was prepared and used. It was sufficiently applied with a brush once a day to the back area per mouse individual.

전체적인 치료 효과의 판정은 실험 시작 후 20일 후의 양모 및 발모 여부를 투약전과 비교하여 매우 호전(++), 호전(+), 조금 호전(±), 무반응(-) 등의 4단계로 분류 판정하였다.The overall treatment effect was judged into 4 stages: very improved (++), improved (+), slightly improved (±), and non-response (-) compared to the condition before administration of the hair and hair growth 20 days after the start of the experiment. judged.

모발 성장기 유도 촉진 작용 평가 결과Results of evaluation of hair growth phase induction promoting action 시료sample 마리수Marisu ++++ ++ ±± -- 부형약excipient -- -- 22 88 대조약reference drug 1One 22 33 44 실시예Example 33 33 22 22

상기 표 2와 같이, 본 발명 실시예의 추출액을 도포한 마우스는 제모 부위에 빠른 속도로 발모가 이루어졌음을 알 수 있다.As shown in Table 2 above, it can be seen that the mice coated with the extract of the present invention experienced rapid hair growth in the hair removal site.

Claims (5)

희토류 복합바이오광물질의 증류추출액을 활성성분으로 함유하는 탈모방지 및 모발성장 촉진제 조성물.A composition for preventing hair loss and promoting hair growth, comprising a distillate extract of rare earth complex biominerals as an active ingredient. 제 1항에 있어서,
상기 희토류 복합바이오광물질은 F 0.1~0.2중량%, Na2O 0.1~0.2중량%, MgO 0.08~0.09중량%, Al2O3 34.0~35.0중량%, SiO2 58.0~59.0중량%, P2O5 0.04~0.05중량%, SO3 0.01~0.02중량%, Cl 0.003~0.004중량%, K2O 2.8~2.9중량%, CaO 0.008~0.009중량%, TiO2 1.5~1.6중량%, Cr2O3 0.01~0.02중량%, MnO 0.01~0.02중량%, Fe2O3 1.0~2.0중량%, NiO 0.005~0.006중량%, CuO 0.002~0.003중량%, Ga2O5 0.006~0.007중량%, SrO 0.02~0.03중량%, Y2O3 0.005~0.006중량%, ZrO2 0.02~0.03중량%, BaO 0.05~0.06중량%, ReO2 0.006~0.007중량%, PbO 0.004~0.005중량%, TbO2 0.002~0.003중량%, Pa 0.02~0.03중량%를 포함하는 것을 특징으로 하는 탈모방지 및 모발성장 촉진제 조성물.
The method of claim 1,
The rare earth composite bio-mineral material is F 0.1 to 0.2 wt%, Na 2 O 0.1 to 0.2 wt%, MgO 0.08 to 0.09 wt%, Al 2 O 3 34.0 to 35.0 wt%, SiO 2 58.0 to 59.0 wt%, P 2 O 5 0.04~0.05 wt%, SO 3 0.01~0.02 wt%, Cl 0.003~0.004 wt%, K 2 O 2.8~2.9 wt%, CaO 0.008~0.009 wt%, TiO 2 1.5~1.6 wt%, Cr 2 O 3 0.01 to 0.02 wt%, MnO 0.01 to 0.02 wt%, Fe 2 O 3 1.0 to 2.0 wt%, NiO 0.005 to 0.006 wt%, CuO 0.002 to 0.003 wt%, Ga 2 O 5 0.006 to 0.007 wt%, SrO 0.02 to 0.03 wt%, Y 2 O 3 0.005 to 0.006 wt%, ZrO 2 0.02 to 0.03 wt%, BaO 0.05 to 0.06 wt%, ReO 2 0.006 to 0.007 wt%, PbO 0.004 to 0.005 wt%, TbO 2 0.002 to 0.003 wt% %, Pa 0.02 to 0.03% by weight of hair loss prevention and hair growth promoter composition, characterized in that it comprises.
제 1항에 있어서, 상기 증류추출액은,
상기 희토류 복합바이오광물질을 물과 함께 증류기에 넣고 온도 110~130℃로 1~10시간 동안 가열한 후, 증류시켜 얻어진 것을 특징으로 하는 탈모방지 및 모발성장 촉진제 조성물.
According to claim 1, wherein the distillate extract,
The composition for preventing hair loss and promoting hair growth, characterized in that the rare earth complex biomineral is put in a distiller together with water and heated at a temperature of 110 to 130° C. for 1 to 10 hours, followed by distillation.
제 1항에 있어서,
상기 증류추출액과 함께 어성초, 측백잎, 모려분, 유근피, 백선피, 및 지실의 증류추출액을 더 포함하는 것을 특징으로 하는 탈모방지 및 모발성장 촉진제 조성물.
The method of claim 1,
Anti-hair loss and hair growth promoter composition, characterized in that it further comprises a distillate extract of eoseongcho, chrysanthemum leaf, morya powder, eugeunpi, baekseonpi, and lichen together with the distillate extract.
제 4항에 있어서,
상기 증류추출액 10~70중량%, 어성초 1~20 중량%, 녹차잎 1~20중량%, 박화수잎 1~20중량%, 측백잎 1~20중량%, 및 소엽 1~20중량%를 증류기에 투입하여 증류시켜 얻어진 피부개선추출액을 포함하는 것을 특징으로 하는 탈모방지 및 모발성장 촉진제 조성물.
5. The method of claim 4,
10 to 70% by weight of the distillation extract, 1 to 20% by weight of Eoseongcho, 1 to 20% by weight of green tea leaves, 1 to 20% by weight of squash leaves, 1 to 20% by weight of arborvitae leaf, and 1 to 20% by weight of leaflets in a distillation A composition for preventing hair loss and promoting hair growth, characterized in that it contains a skin improvement extract obtained by distillation by input.
KR1020210000835A 2021-01-05 2021-01-05 Composition for preventing alopecia and activating growth of hair comprising distilled extract of rare earth complexbiomineral KR102489107B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020210000835A KR102489107B1 (en) 2021-01-05 2021-01-05 Composition for preventing alopecia and activating growth of hair comprising distilled extract of rare earth complexbiomineral

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020210000835A KR102489107B1 (en) 2021-01-05 2021-01-05 Composition for preventing alopecia and activating growth of hair comprising distilled extract of rare earth complexbiomineral

Publications (2)

Publication Number Publication Date
KR20220099189A true KR20220099189A (en) 2022-07-13
KR102489107B1 KR102489107B1 (en) 2023-01-18

Family

ID=82401166

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020210000835A KR102489107B1 (en) 2021-01-05 2021-01-05 Composition for preventing alopecia and activating growth of hair comprising distilled extract of rare earth complexbiomineral

Country Status (1)

Country Link
KR (1) KR102489107B1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010501551A (en) * 2006-08-25 2010-01-21 テウン イーエルエス インコーポレイテッド Use of rare earth elements for hair improvement
KR20180134501A (en) * 2017-06-09 2018-12-19 삼일오 주식회사 Composition of fire-proofing materials and manufacturing method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010501551A (en) * 2006-08-25 2010-01-21 テウン イーエルエス インコーポレイテッド Use of rare earth elements for hair improvement
KR20180134501A (en) * 2017-06-09 2018-12-19 삼일오 주식회사 Composition of fire-proofing materials and manufacturing method thereof

Also Published As

Publication number Publication date
KR102489107B1 (en) 2023-01-18

Similar Documents

Publication Publication Date Title
KR20200013571A (en) Composition for Preventing Hair Loss or Promoting Hair Growth
KR102309300B1 (en) Functional cosmetic composition for skin wrinkle improvement
KR102489107B1 (en) Composition for preventing alopecia and activating growth of hair comprising distilled extract of rare earth complexbiomineral
KR102596741B1 (en) Hybrid liposome conjugated extracellular vesicles derived callus of plant and coenzyme q10 liposome and the use thereof
KR102076179B1 (en) A cosmetic composition for alleviating skin irritation by vitamin c containing a mixed extract of iris lactea and doellingeria scabra
KR102380191B1 (en) Cosmetic composition for improving acne containing Ficus erecta var. sieboldii extracts as active ingredient
KR102142228B1 (en) Composition for hair loss prevention and hair growth promoting containing colostrum, biotin and guarana extract and preparation method therof
JP3090156B2 (en) Cosmetics
KR20170110910A (en) Hair growth activating composition comprising leaf extract of conifer containing pinane
KR20050077310A (en) Hair and eyebrow, eyelashes growth stimulater using indigo extracts
KR20130000121A (en) Composition for preventing alopecia and activating growth of hair
KR102622831B1 (en) A composition for prevention or improvement of hair loss comprising setaria italica beauv. extract
KR20150051751A (en) Composition for treating hair or scalp to prevent hair loss
KR101348006B1 (en) Topical preparations for hair growth
KR100681699B1 (en) Hair Cosmetic Composition for Treating Dandruff Comprising Mung Bean Extract as Active Ingredient
WO2022255799A1 (en) Composition for preventing hair loss and promoting hair growth, containing gypsophila paniculata l.
KR102172355B1 (en) Cosmetic composition for skin sebum control comprising rx complex s
KR101044068B1 (en) Composition for preventing alopecia and promoting hair growth comprising arisaematis rhizoma extract
KR102315713B1 (en) External composition for inhibiting hair loss and/or promoting hair growth
KR102113866B1 (en) Cosmetic composition comprising extract of centella asiatica
KR20220137618A (en) External composition for preventing hair loss and/or promoting hair growth
KR20210082071A (en) Composition for preventing hair loss and promoting hair growth
KR20220098938A (en) Skin external composition comprising distilled extract of rare earth complexbiomineral for alleviating skin allergy
KR101652070B1 (en) Composition containing Tribulus Terrestris fruit extract for skin volume augmentation or improving wrinkle and elasticity
JP2000169497A (en) New triterpene and composition including the same

Legal Events

Date Code Title Description
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant